Summary. The high plasma calcitonin level in the mother during gestation and lactation protected the maternal skeleton against excessive demineralization. The relative independence of fetal calcemia from the maternal plasma calcium concentration was well established and the concept of hormonal autonomy of fetal secretion of parathyroid hormone and calcitonin developed. However, the role of these hormones during fetal life remained obscure. A new aspect of calcitonin physiology in the newborn, the regulation of nutrient absorption through gastric emptying, is mentioned.
Parathyroid hormone which stimulates bone resorption and intestinal absorption through vitamin D metabolites may be responsible for these physiological changes. Indeed, the works of Cushard et al. (1972) and of Bouillon and De Moor (1973) show that the plasma levels of immunoreactive parathyroid hormone increased during the last three months of pregnancy in humans. In cows fed a normal calcium diet, plasma parathyroid hormone levels were very high in the last two months of gestation (Black, Capen and Arnaud, 1973) .
Thus, it is tempting to speculate that a factor might regulate the loss of calcium from the maternal skeleton during gestation and lactation. Calcitonin (CT), a hypocalcemic and hypophosphatemic hormone, acts by inhibiting bone resorption and these effects are more intense as bone resorption is enhanced. The role ofCT might be important during gestation and lactation, as proposed by Konopka, Klotz and Delorme (1971) and suggested the same year by Lewis et al. (1971) .We have shown that the jugular venous plasma CT concentrations ( fig. 1 ) were higher in pregnant ewes than in control animals at the end of gestation and during lactation in spite of the absence of any difference in plasma calcium levels. The highest CT levels were measured in animals bearing triplets in which the rate of placental transfer of calcium is very high : 5.4 g/day versus 1.7 g/day in animals bearing a singleton (Field and Suttle, 1967 . Salmi (1954) (Garel, 1970a ; Pic, Maniey and Jost, 1965 ; Pic, 1973) which is corrected by parathyroid extract injection (Garel, Pic and Jost, 1971) (table 1) . Thyroparathyroidectomy in rat fetus delayed recovery from EDTA-induced hypocalcemia (Garel, 1975) . Higher calcemia in the fetus than in the mother in thyroparathyroidectomized rat fetus from thyroparathyroidectomized mother (Pic, 1968) (Pic, 1969) . The simultaneous developmental changes in proteinemia indicated that high calcium affinity of fetal proteins was probably not involved in fetal hypercalcemia since fetal plasma protein level was extremely low at the earliest stage studied (16.5 days). Moreover, there is no correlation between fetal calcemia and fetal proteinemia during the last week of gestation , the highest level being observed in 16.5-day old rat fetus. Plasma level of inorganic phosphorus was also higher in the fetus than in the mother during the last week of gestation in rats (Garel and Pic, 1972 (Garel, Care and Barlet, 1974) . Calcium infusion in the pregnant ewe did not change fetal calcemia (Garel et (Garel, Milhaud and Jost, 1968) . A larger dose (140 MRC mU/g body weight of salmon CT) must be given to decrease the fetal plasma magnesium level . In preliminary experiments, Littledike, Arnaud and Whipp (1972) have shown that CT injected intravenously into fetal piglet had no effect on plasma calcium levels in contrast to newborn piglet. In Rhesus monkey fetus, CT induced a triphasic effect with time on the plasma calcium level : a rapid decline, followed by recovery, and then a sluggish decrease (Reynolds, Pitkin and Wezeman, 1975) . The intensity of bone resorption at the end of gestation in rat fetus is unknown, but the hypocalcemic effect of CT was probably the result of bone resorption inhibition since in vitro CT inhibits the release of calcium 45 in the culture medium of radius from 19-day old rat fetus (Friedman and Raisz, 1965).We must note that the in vivo effect was very slight after injection of a large dose of CT and indicated poor bone resorption. In the rat fetus, the plasma calcium level decreased after 19.5 days of gestation leading to the conclusion that CT secretion begins at this stage since from the 20th day onwards there is a marked increase in secretory activity of the thyroid c C» cells (Stoeckel and Porte, 1970) . Thyroid glands from 19-day old rat fetus in culture secrete an inhibitor of bone resorption in amounts directly proportional to the calcium concentration of the medium (Feinblatt and Raisz, 1971 The Newborn.
The placental outflow of calcium disappears at birth and the plasma calcium level decreases sharply in newborn rat (Garel, 1969) . The hypocalcemic and hypophosphatemic effects of CT were more intense in the newborn rat than in rat fetus (Garel, 1969 ; Garel and Barlet,1974) ; the newborns were also more sensitive to the hormone since subcutaneous injection of a lower dose (1:5) markedly decreased plasma calcium and inorganic phosphorus concentrations . The injection of a large dose of CT in the suckling newborn rat had a clearing effect on plasma which was naturally lactescent (Garel, Barlet and Kervran, 1975) . The clearing effect of CT was the result of a decrease in plasma lipids, as shown by the decrease in plasma triglyceride concentration ( fig. 9 ). Stomach gavage of triolein 14 C has demonstrated that 3 h after administration, CT induced a decrease in the weight of the gastric contents and their radioactivity ( fig. 10 ). This observation indicated an inhibition of gastric emptying which was illustrated again by the percentage of triolein-14 C absorbed 3 h after CT injection (75 p. 100 in controls 4 h after force-feeding as opposed to 43 p. 100 in CT-treated animals). The tissue distribution of radioactivity 4 h after forcefeeding illustrated the decrease in the absorption of labelled triolein. The distribution of radioactivity in control animals was very high in brown adipose tissue, but low in liver, kidney, muscle and bone ; 3 h after CT injection, the distribution of radioactivity for each organ studied was less in the CT group than in control animals (Garel, Barlet and Kervran, 1975 
